<DOC>
	<DOCNO>NCT01527747</DOCNO>
	<brief_summary>The purpose study test effect saxagliptin , treatment diabetes , fast post-meal blood triglyceride ( blood fat ) level .</brief_summary>
	<brief_title>Effects DPP-4 Inhibition Triglycerides</brief_title>
	<detailed_description>This study design help u understand effect DPP-4 inhibition triglyceride level ad eating .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>Willing provide sign write informed consent Men woman age 1880 year Type 2 diabetes ( define ADA see reference 18 ) Baseline HgbA1c 6.5 % 8 % ; HgbA1c 7.58.0 % among subject take sulfonylureas Baseline plasma triglyceride concentration 200 700 mg/dl Stable diabetes medication regimen least 12 week prior study entry Taking statin least 8 week , unless statin therapy contraindicate intolerable Treatment lipidlowering medication dose stable &gt; 8 week . Nonsmoker Body mass index &lt; 45.0 kg/m2 BP &lt; 140/85 Normal serum TSH free T4 concentration ( hypothyroid subject take stable replacement dose levothyroxine allow biochemically euthyroid ) Subjects otherwise healthy Women childbearing potential must willing use reliable contraception , define IRB , throughout study ( There currently FDA recommend restriction use saxagliptin sexually active men , requirement contraception wife sexual partner ) Able willing complete study procedure Transaminase concentration &gt; 2 time ULN . ( Mild elevation AST ALT allow 2x ULN baseline evidence viral hepatitis intrinsic liver disease . Since many subject may degree hepatic steatosis , key intervention implementation treatment low glucose triglyceride ) Estimated creatinine clearance &lt; 60 ml/min Microalbumincreatinine ratio &gt; 120 Alcohol consumption &gt; 1 drink daily woman &gt; 2 drink daily men Pancreatitis within precede 6 month Type 1 diabetes History diabetic ketoacidosis ( DKA ) Cardiovascular disease ( CAD , stroke , PVD ) Known human immunodeficiency virus ( HIV ) infection Viral hepatitis Pregnancy lactation A current diagnosis active nondermatologic cancer Other lifethreatening illness History small bowel resection gastric bypass surgery Use glucocorticoid medication , beta blocker , thiazide diuretic , excess alcohol intake ( betablockers thiazide diuretic allow , necessary , dose stable &gt; 12 week prior study entry dose remain stable throughout study . Complete exclusion drug would exclude substantial proportion diabetic patient ) Use systemic cytochrome P450 3A4 ( CYP 3A4/5 ) inhibitor ketaconazole , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir telithromycin . Current enrollment another research study use investigational drug within 90 day study entry Other medical condition may interfere participation study , opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Hypertriglyceridemia</keyword>
	<keyword>dipeptidyl peptidase-4 ( DPP-4 )</keyword>
	<keyword>glucagon-like peptide-1 ( glp-1 )</keyword>
</DOC>